Deutsche Bank AG Makes New Investment in Teleflex Incorporated $TFX

Deutsche Bank AG acquired a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 48,171 shares of the medical technology company's stock, valued at approximately $6,106,000. Deutsche Bank AG owned 0.11% of Teleflex at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Hsbc Holdings PLC boosted its stake in Teleflex by 4.7% during the 1st quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company's stock worth $222,000 after acquiring an additional 84 shares during the last quarter. Banque Cantonale Vaudoise grew its holdings in Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock valued at $31,000 after purchasing an additional 113 shares during the period. Hantz Financial Services Inc. increased its stake in Teleflex by 40.5% in the fourth quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company's stock valued at $48,000 after purchasing an additional 113 shares in the last quarter. UMB Bank n.a. increased its stake in Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company's stock valued at $38,000 after purchasing an additional 113 shares in the last quarter. Finally, Maryland State Retirement & Pension System raised its holdings in Teleflex by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company's stock worth $1,056,000 after purchasing an additional 129 shares during the period. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $138.31 on Tuesday. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $145.00. The company's 50 day moving average price is $132.87 and its two-hundred day moving average price is $125.13. The firm has a market cap of $5.86 billion, a PE ratio of -5.94, a PEG ratio of 0.93 and a beta of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.48. The business had revenue of $570.33 million for the quarter, compared to analysts' expectations of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The firm's quarterly revenue was up 28.9% compared to the same quarter last year. During the same period last year, the firm posted $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities research analysts predict that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex's dividend payout ratio is -5.84%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on TFX. Raymond James Financial reiterated an "outperform" rating and set a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Needham & Company LLC raised their target price on shares of Teleflex from $147.00 to $159.00 and gave the stock a "buy" rating in a report on Friday, July 31st. Wells Fargo & Company lifted their price target on shares of Teleflex from $130.00 to $138.00 and gave the company an "equal weight" rating in a research note on Friday, May 8th. Royal Bank Of Canada upgraded shares of Teleflex from a "sector perform" rating to an "outperform" rating and upped their price target for the company from $135.00 to $155.00 in a report on Friday, May 8th. Finally, Mizuho increased their price objective on shares of Teleflex from $140.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $151.80.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source